Personal information

No personal information available

Activities

Collapse all

Works (26)

Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.

Cancers
2021-10-22 | Journal article
DOI: 10.3390/cancers13215301
PMID: 34771465
PMC: PMC8582574
Source: Self-asserted source
Scott E. Woodman

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy.

Cell reports
2021-07-01 | Journal article
DOI: 10.1016/j.celrep.2021.109410
PMID: 34289358
PMC: PMC8369408
Source: Self-asserted source
Scott E. Woodman

The genetic and epigenetic basis of distinct melanoma types

The Journal of Dermatology
2021-05 | Journal article
DOI: 10.1111/1346-8138.15957
Part of ISSN: 0385-2407
Contributors: Junna Oba; Scott E. Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma

Melanoma Research
2020-09 | Journal article
DOI: 10.1097/cmr.0000000000000694
Part of ISSN: 0960-8931
Contributors: Jane Mattei; Alexej Ballhausen; Roland Bassett; Michael Shephard; Chandrani Chattopadhyay; Courtney Hudgens; Michael Tetzlaff; Scott Woodman; Takami Sato; Sapna P. Patel
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.

Investigative ophthalmology & visual science
2019-10-01 | Journal article
DOI: 10.1167/iovs.19-28082
PMID: 31596927
PMC: PMC6785781
Source: Self-asserted source
Scott E. Woodman

Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.

JCO clinical cancer informatics
2019-09-01 | Journal article
DOI: 10.1200/cci.19.00089
PMID: 31550176
PMC: PMC6874004
Source: Self-asserted source
Scott E. Woodman
grade
Preferred source (of 2)‎

Abstract 2357: Identification of microRNAs associated with melanoma immunity and immunotherapy outcome

Immunology
2019-07-01 | Other
DOI: 10.1158/1538-7445.am2019-2357
Contributors: Robert A. Szczepaniak Sloane; Miles C. Andrews; Guangchun Han; Lauren Haydu; Elizabeth Burton; Gershenwald E. Jeffrey; Michael A. Davies; Linghua Wang; Scott Woodman; Jennifer Wargo
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Immune checkpoint inhibitor responses in KIT-mutated metastatic melanoma.

Journal of Clinical Oncology
2018-02-10 | Journal article
DOI: 10.1200/jco.2018.36.5_suppl.199
Part of ISSN: 0732-183X
Contributors: Meredith Ann McKean; Junna Oba; Junsheng Ma; Lauren Elaine Haydu; Roland L. Bassett; Scott Eric Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

NPJ genomic medicine
2017-04-07 | Journal article
DOI: 10.1038/s41525-017-0013-8
PMID: 28819565
PMC: PMC5557036
Source: Self-asserted source
Scott E. Woodman

Uveal melanoma: From diagnosis to treatment and the science in between

Cancer
2016-03 | Journal article
DOI: 10.1002/cncr.29727
Part of ISSN: 0008-543X
Contributors: Chandrani Chattopadhyay; Dae Won Kim; Dan S. Gombos; Junna Oba; Yong Qin; Michelle D. Williams; Bita Esmaeli; Elizabeth A. Grimm; Jennifer A. Wargo; Scott E. Woodman et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

Clinical Cancer Research
2016-01 | Journal article
DOI: 10.1158/1078-0432.ccr-15-2226
Part of ISSN: 1078-0432
Contributors: Suhendan Ekmekcioglu; Michael A. Davies; Keiji Tanese; Jason Roszik; Myung Shin-Sim; Roland L. Bassett; Denái R. Milton; Scott E. Woodman; Victor G. Prieto; Jeffrey E. Gershenwald et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Identification of potentially actionable mutations in RTKs in melanoma detected by next generation sequencing (NGS).

Journal of Clinical Oncology
2015-05 | Journal article
DOI: 10.1200/jco.2015.33.15_suppl.9064
Part of ISSN: 0732-183X
Contributors: Jan Kemnade; Jason Roszik; Aron Joon; Franceso Stingo; Veera Baladandayuthapani; Alexander J. F. Lazar; Scott Eric Woodman; Michael A. Davies
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Genetic analysis of the ‘uveal melanoma’ C918 cell line reveals atypical<i>BRAF</i>and common<i>KRAS</i>mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line

Pigment Cell &amp; Melanoma Research
2015-03 | Journal article
DOI: 10.1111/pcmr.12345
Part of ISSN: 1755-1471
Contributors: Xiaoxing Yu; Grazia Ambrosini; Jason Roszik; Agda Karina Eterovic; Katherine Stempke-Hale; Elisabeth A. Seftor; Chandrani Chattopadhyay; Elizabeth Grimm; Richard D. Carvajal; Mary J. C. Hendrix et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma

Melanoma Research
2014-08 | Journal article
DOI: 10.1097/cmr.0000000000000062
Part of ISSN: 0960-8931
Contributors: Anas Alrwas; Nicholas E. Papadopoulos; Suzanne Cain; Sapna P. Patel; Kevin B. Kim; Tawania L. Deburr; Roland Bassett; Wen-Jen Hwu; Agop Y. Bedikian; Michael A. Davies et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration

PLoS ONE
2014-02 | Journal article
DOI: 10.1371/journal.pone.0083957
Part of ISSN: 1932-6203
Contributors: Chandrani Chattopadhyay; Elizabeth A. Grimm; Scott E. Woodman; Keiran Smalley
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

<i>BRAF</i>,<i>NRAS</i>and<i>KIT</i>sequencing analysis of spindle cell melanoma

Journal of Cutaneous Pathology
2012-07 | Journal article
DOI: 10.1111/j.1600-0560.2012.01950.x
Part of ISSN: 0303-6987
Contributors: Jinhyun Kim; Alexander J. Lazar; Michael A. Davies; Jade Homsi; Nicholas E. Papadopoulos; Wen-jen Hwu; Agop Y. Bedikian; Scott E. Woodman; Sapna P. Patel; Patrick Hwu et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Phase I/II study of LOC-paclitaxel (LOC-Pac) in patients (pts) with metastatic melanoma.

Journal of Clinical Oncology
2012-05 | Journal article
DOI: 10.1200/jco.2012.30.15_suppl.e19039
Part of ISSN: 0732-183X
Contributors: Agop Y. Bedikian; Kevin B. Kim; Nicholas E. Papadopoulos; Wen-Jen Hwu; Sapna Pradyuman Patel; Michael A. Davies; Sandy Mahoney; Patrick Hwu; Scott Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

KIT Mutations in Melanoma: Where Are We Now?

AACR Education book
2012-04 | Journal article
DOI: 10.1158/aacr.edb-12-1609
Part of ISSN: 1943-6475
Contributors: S. Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Metastatic Uveal Melanoma

The Cancer Journal
2012-03 | Journal article
DOI: 10.1097/ppo.0b013e31824bd256
Part of ISSN: 1528-9117
Contributors: Scott E. Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Genetic and molecular characterization of uveal melanoma cell lines

Pigment Cell &amp; Melanoma Research
2012-02-02 | Journal article
DOI: 10.1111/j.1755-148x.2012.00971.x
Part of ISSN: 1755-1471
Contributors: K. G. Griewank; X. Yu; J. Khalili; M. M. Sozen; K. Stempke-Hale; C. Bernatchez; S. Wardell; B. C. Bastian; S. E. Woodman
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition

Pigment Cell &amp; Melanoma Research
2012-01 | Journal article
DOI: 10.1111/j.1755-148x.2011.00950.x
Part of ISSN: 1755-1471
Contributors: W. Deng; Y. N. Vashisht Gopal; A. Scott; G. Chen; S. E. Woodman; M. A. Davies
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Profile of ipilimumab and its role in the treatment of metastatic melanoma

Drug Design, Development and Therapy
2011 | Journal article
DOI: 10.2147/dddt.s10945
Part of ISSN: 1177-8881
Contributors: Scott Woodman; Patel
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Ipilimumab plus temozolomide in metastatic melanoma.

Journal of Clinical Oncology
2011-05 | Journal article
DOI: 10.1200/jco.2011.29.15_suppl.8579
Part of ISSN: 0732-183X
Contributors: S. P. Patel; A. Y. Bedikian; N. E. Papadopoulos; W. Hwu; K. B. Kim; J. Homsi; M. A. Davies; S. E. Woodman; L. G. Radvanyi; K. Woodard et al.
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics

Biochemical Pharmacology
2010-09 | Journal article
DOI: 10.1016/j.bcp.2010.04.032
Part of ISSN: 0006-2952
Contributors: Scott E. Woodman; Michael A. Davies
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Selective activity of dasatinib for the most common KIT mutation in melanoma (L576P)

Journal of Clinical Oncology
2009-05 | Journal article
DOI: 10.1200/jco.2009.27.15_suppl.9019
Part of ISSN: 0732-183X
Contributors: S. E. Woodman; J. C. Trent; K. Stemke-Hale; A. Lazar; S. Pricl; G. M. Pavan; N. Papadopoulos; P. Hwu; G. B. Mills; M. A. Davies
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib

Nature Clinical Practice Oncology
2008-10 | Journal article
DOI: 10.1038/ncponc1251
Part of ISSN: 1743-4254
Contributors: Alfonso Quintás-Cardama; Alexander J Lazar; Scott E Woodman; Kevin Kim; Merrick Ross; Patrick Hwu
Source: Self-asserted source
Scott E. Woodman via Crossref Metadata Search
How many people are using ORCID?